2004
DOI: 10.1007/s00213-004-2031-3
|View full text |Cite
|
Sign up to set email alerts
|

Differential effects of intra-midbrain raph� and systemic 8-OH-DPAT on VTA self-stimulation thresholds in rats

Abstract: These results confirm threshold-decreasing effects of intra-MRN 8-OH-DPAT and extend this to the DRN and to VTA thresholds. Monophasic dose dependent increases in VTA thresholds following systemic 8-OH-DPAT are not equivalent to reports for hypothalamic self-stimulation. Differences between studies may be attributable to stimulation site and/or differences in threshold measurement procedures. Effects of WAY 100635 in this study indicate 5-HT(1A) receptor mediation of these 8-OH-DPAT effects.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
10
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 49 publications
2
10
0
Order By: Relevance
“…This lack of abuse-related effect in an ICSS procedure agrees with a previous report that flibanserin failed to produce a conditioned place preference in male rats [13]. Conversely, the present results with flibanserin contrast with effects in rats reported for relatively low doses of the 5HT1A agonist 8-OH-DPAT, which usually facilitates ICSS [16, 17] (but see [42]) and produces conditioned place preferences [15]. The present results are not likely to reflect evaluation of an inadequate flibanserin dose range, because flibanserin was tested across a 10-fold dose range from low doses that produced no effect to high doses that only depressed ICSS, and flibanserin doses tested here also produce a range of other behavioral effects in rats (e.g.…”
Section: Discussionsupporting
confidence: 93%
“…This lack of abuse-related effect in an ICSS procedure agrees with a previous report that flibanserin failed to produce a conditioned place preference in male rats [13]. Conversely, the present results with flibanserin contrast with effects in rats reported for relatively low doses of the 5HT1A agonist 8-OH-DPAT, which usually facilitates ICSS [16, 17] (but see [42]) and produces conditioned place preferences [15]. The present results are not likely to reflect evaluation of an inadequate flibanserin dose range, because flibanserin was tested across a 10-fold dose range from low doses that produced no effect to high doses that only depressed ICSS, and flibanserin doses tested here also produce a range of other behavioral effects in rats (e.g.…”
Section: Discussionsupporting
confidence: 93%
“…However, the direction (positive or negative) of its effects should be analyzed carefully because it may vary depending on the method used to modulate 5-HT levels (e.g., systemic or local), the location of self-stimulation (Ahn et al, 2005), or the kinds of behavioral test used (Mosher et al, 2005; Hayes et al, 2009). …”
Section: -Ht and The Reward Circuitmentioning
confidence: 99%
“…Within these genes two single nucleotide polymorphisms (SNPs), rs6295 and rs6311, code for receptor 5-HT1A and receptor 5-HT2A, respectively. Administration of a 5-HT1A agonist, 8-OH-DPAT, increased reward in rodents (Ahn et al, 2005), and reinforced the rewarding properties of cocaine in monkeys (Czoty, McCabe & Nader, 2005). The 5-HT2A seems integral in mediating the effects of some abused drugs such as 3,4-methylenedioxy- N -methylamphetamine (MDMA) (Liechti, Saur, Gamma, Hell & Vollenweider, 2000).…”
Section: Introductionmentioning
confidence: 99%